Eosinophilic fasciitis as an immune-related adverse event of Pembrolizumab in Hodgkin’s lymphoma: a case report
BACKGROUND: Immune checkpoint inhibitors have transformed the treatment landscape for several types of cancer. These agents boost the patient's immune system by targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 (PD-1), and its ligand. However, the enhanc...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Khyber Medical University
2024-06-01
|
| Serie: | Khyber Medical University Journal |
| Soggetti: | |
| Accesso online: | https://www.kmuj.kmu.edu.pk/article/view/23588 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|